Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

2025.03.03 22:00:00
스팸방지
0 / 300
  • facebook
  • youtube
  • twitter
  • 네이버블로그
  • instagram
  • 키키오채널